Equities Tech

Amazon shares news: Tech giant hires eminent cardiologist in medical sector push

Share this article!

Amazon shares ended lower in the US Monday, amid reports the tech giant has hired star cardiologist, Maulik Majmudar, MD. The news comes as the global behemoth continues its push into the medical sector. It’s not yet clear exactly which of Amazon’s medical-related teams its latest new hire will join.

Amazon shares ended the US Monday session 0.29% lower at $1,876.71. The stock is also a little in the red in out-of-hours activity.

Amazon hires top cardiologist

Majmudar shared the news of his new venture in a tweet Monday.

“1/ Very emotional day: After decade of medical training (@NorthwesternMed @HopkinsMedicine @BrighamWomens), five years on the faculty @MGHMedicine and @harvardmed, leading #digitalhealth @mgh_htl, I have decided to leave academia to take on an exciting & challenging role @amazon,” he said on Twitter.

Majmudar has held a number of prominent medical roles.

Most recently, he was a cardiologist at Massachusetts General Hospital and also associate director of the health-care transformation lab there, where his role included how to bring the latest in medical tech into practise at the hospital.

In addition, Majmudar lectured at MIT and in the past has advised tech businesses in the past, over potential forays into the health sector.

No firm details

However, so far, no further details on exactly what he will be doing at the firm, have been shared. There are, though, a variety of options for the tech firm.

Amazon is looking to move into the US healthcare sector in a variety of ways. One of which is through employee healthcare provision in a joint venture with Berkshire Hathaway and JP Morgan.

The tech giant is also selling AI and other tech to healthcare companies. And, Amazon is also reportedly working on becoming a main supplier of healthcare products and drugs to the huge US sector.

Add Comment

Investing is speculative. When investing your capital is at risk. This site is not intended for use in jurisdictions in which the trading or investments described are prohibited and should only be used by such persons and in such ways as are legally permitted. Your investment may not qualify for investor protection in your country or state of residence, so please conduct your own due diligence. This website is free for you to use but we may receive commission from the companies we feature on this site. Click here for more information.